MIM
ALKS icon

MetLife Investment Management’s Alkermes ALKS Stock Holding History

MetLife Investment Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9M Buy
512,924
+424,072
+477% +$16.6M 0.12% 123
2026
Q1 		$3.14M Sell
88,852
-441,527
-83% -$13.7M 0.02% 823
2025
Q4 		$14.8M Sell
530,379
-176,817
-25% -$5.3M 0.07% 254
2025
Q3 		$21.2M Buy
707,196
+50,548
+8% +$1.43M 0.1% 153
2025
Q2 		$18.8M Buy
656,648
+89,027
+16% +$2.65M 0.11% 166
2025
Q1 		$18.7M Buy
567,621
+470,926
+487% +$15.4M 0.1% 166
2024
Q4 		$2.78M Buy
96,695
+3,492
+4% +$100K 0.02% 879
2024
Q3 		$2.61M Sell
93,203
-3,998
-4% -$107K 0.02% 886
2024
Q2 		$2.34M Buy
97,201
+11,500
+13% +$282K 0.01% 898
2024
Q1 		$2.32M Sell
85,701
-1,730
-2% -$49.1K 0.02% 895
2023
Q4 		$2.43M Hold
87,431
– – 0.02% 875
2023
Q3 		$2.45M Hold
87,431
– – 0.02% 814
2023
Q2 		$2.74M Buy
87,431
+2,152
+3% +$65.2K 0.02% 795
2023
Q1 		$2.4M Sell
85,279
-1,436
-2% -$39.1K 0.02% 854
2022
Q4 		$2.27M Hold
86,715
– – 0.02% 850
2022
Q3 		$1.94M Buy
86,715
+2,182
+3% +$56.8K 0.02% 897
2022
Q2 		$2.52M Sell
84,533
-1,817
-2% -$52.2K 0.02% 803
2022
Q1 		$2.27M Buy
86,350
+28,879
+50% +$715K 0.01% 944
2021
Q4 		$1.34M Hold
57,471
– – 0.01% 1013
2021
Q3 		$1.77M Hold
57,471
– – 0.02% 914
2021
Q2 		$1.41M Buy
+57,471
New +$1.28M 0.01% 1006
2019
Q2 		– Sell
-211
Closed -$7.7K – 2430
2019
Q1 		$7.7K Buy
211
+1
+0.5% +$33 ﹤0.01% 2530
2018
Q4 		$6.2K Sell
210
-2
-0.9% -$74 ﹤0.01% 2440
2018
Q3 		$9K Buy
+212
New +$9.2K ﹤0.01% 2453

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MetLife Investment Management's ALKS Position: Q2 2026 in Review

MetLife Investment Management increased its Alkermes (ALKS) stake by 477% in Q2 2026, buying an estimated $16.6M and bringing the position to 512,924 shares worth $26.9M. The position accounts for 0.12% of the portfolio, ranked #123.

MetLife Investment Management first reported a position in ALKS in Q3 2018 and has held it in 24 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • MetLife Investment Management held 512,924 shares of Alkermes worth $26.9M as of Q2 2026.
  • MetLife Investment Management bought 424,072 Alkermes shares in Q2 2026, an estimated $16.6M.
  • Alkermes made up 0.12% of MetLife Investment Management's portfolio in Q2 2026, its #123 holding.
  • MetLife Investment Management first reported a position in Alkermes in Q3 2018 and has held it in 24 quarters since.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.